{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:37:49Z","timestamp":1792607869725,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Teggers Foundation"},{"name":"MultiPark \u2013 Lund University\u2019s Strategic Research Area in Neuroscience"},{"name":"Swedish Parkinson Academy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nurs"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder affecting motor and non-motor functions. When oral medication no longer provides adequate control, device-aided therapies (DAT), including levodopa infusion therapy, may be introduced. Although DAT can improve symptom management, little is known about how people with PD (PwPD) and family caregivers (FC) experience the initiation process. This study explored PwPD and their FC perceptions during decision-making, therapy initiation, and subsequent adaptation to levodopa pump therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative study employed semi-structured interviews (6\u201324 months after treatment initiation) and latent reflexive thematic analysis with ten PwPD and nine FC recruited from two Swedish university hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thematic analysis revealed four shared themes: (1) Living with the constraints of PD, (2) Sustaining hope in the face of therapeutic uncertainty, (3) Adapting to a new treatment while facing practical challenges, and (4) Relying on expertise while managing its absence. Pump therapy was often chosen due to limited alternatives and strong trust in the specialized multidisciplinary PD team. While both groups experienced symptom improvements, PwPD focused on autonomy whereas FC focused on responsibilities. Expectations were generally met, yet FC frequently felt underinformed about the realities of daily pump management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings highlight that although symptom control improved, both PwPD and FC continued to face practical and emotional challenges. Supporting their adaptation process requires coordinated, person-centred preparation, guidance and follow-up from multidisciplinary, specialized PD teams.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12912-026-05527-6","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:05:39Z","timestamp":1792512339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4415-1428","authenticated-orcid":false,"given":"Monica","family":"Scharfenort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Nobrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Garon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Rosqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria H.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Nyholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Odin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Mangrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"5527_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397:2284\u2013303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X.","journal-title":"Lancet"},{"key":"5527_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 2006;5:235\u201345. https:\/\/doi.org\/10.1016\/S1474-4422(06)70373-8.","journal-title":"Lancet Neurol"},{"key":"5527_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/JPD-130244","volume":"4","author":"D Nyholm","year":"2014","unstructured":"Nyholm D, Stepien V. Levodopa fractionation in Parkinson\u2019s disease. J Parkinsons Dis. 2014;4:89\u201396. https:\/\/doi.org\/10.3233\/JPD-130244.","journal-title":"J Parkinsons Dis"},{"key":"5527_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/practneurol-2012-000463","volume":"13","author":"PF Worth","year":"2013","unstructured":"Worth PF. When the going gets tough: how to select patients with Parkinson\u2019s disease for advanced therapies. Pract Neurol. 2013;13:140\u201352. https:\/\/doi.org\/10.1136\/practneurol-2012-000463.","journal-title":"Pract Neurol"},{"key":"5527_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/jpm11080773","volume":"11","author":"V Leta","year":"2021","unstructured":"Leta V, Dafsari HS, Sauerbier A, Metta V, Titova N, Timmermann L, et al. Personalised advanced therapies in parkinson\u2019s disease: The role of non-motor symptoms profile. J Pers Med. 2021;11:773. https:\/\/doi.org\/10.3390\/jpm11080773.","journal-title":"J Pers Med"},{"key":"5527_CR6","unstructured":"The National Board of Health and Welfare (Socialstyrelsen). V\u00e5rd vid multipel skleros och Parkinsons sjukdom. Indikatorer och underlag f\u00f6r bed\u00f6mning [National guidelines \u2013 evaluation 2016: care in multiple sclerosis and Parkinson\u2019s disease \u2013 indicators and basis for assessment]. Stockholm; 2016."},{"key":"5527_CR7","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s40263-022-00963-9","volume":"36","author":"A Antonini","year":"2022","unstructured":"Antonini A, Pahwa R, Odin P, Isaacson SH, Merola A, Wang L, et al. Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson\u2019s Disease: A Systematic Review and Bayesian Network Meta-analysis. CNS Drugs. 2022;36:1269\u201383. https:\/\/doi.org\/10.1007\/s40263-022-00963-9.","journal-title":"CNS Drugs"},{"key":"5527_CR8","doi-asserted-by":"publisher","unstructured":"Agid Y, Sch\u00fcpbach M, Gargiulo M, Mallet L, Houeto JL, Behar C, et al. Neurosurgery in Parkinson\u2019s disease: the doctor is happy, the patient less so? J Neural Transm Suppl. 2006;409\u201314. https:\/\/doi.org\/10.1007\/978-3-211-45295-0_61.","DOI":"10.1007\/978-3-211-45295-0_61"},{"key":"5527_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1155\/2020\/1561037","volume":"2020","author":"SB Jonasson","year":"2020","unstructured":"Jonasson SB, Rantakokko M, Franz\u00e9n E, Iwarsson S, Nilsson MH. Prediction of Life Satisfaction in People with Parkinson\u2019s Disease. Parkinsons Dis. 2020;2020:4\u20136. https:\/\/doi.org\/10.1155\/2020\/1561037.","journal-title":"Parkinsons Dis"},{"key":"5527_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ane.12695","volume":"136","author":"K Rosqvist","year":"2017","unstructured":"Rosqvist K, Hagell P, Odin P, Ekstr\u00f6m H, Iwarsson S, Nilsson MH. Factors associated with life satisfaction in Parkinson\u2019s disease. Acta Neurol Scand. 2017;136:64\u201371. https:\/\/doi.org\/10.1111\/ane.12695.","journal-title":"Acta Neurol Scand"},{"key":"5527_CR11","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1111\/jocn.14868","volume":"28","author":"L Ambrosio","year":"2019","unstructured":"Ambrosio L, Portillo MC, Rodriguez-Blazquez C, Rojo JM, Martinez-Martin P, Violante MR, et al. Influencing factors when living with Parkinson\u2019s disease: A cross-sectional study. J Clin Nurs. 2019;28:3168\u201376. https:\/\/doi.org\/10.1111\/jocn.14868.","journal-title":"J Clin Nurs"},{"key":"5527_CR12","doi-asserted-by":"publisher","unstructured":"Park J, Kim J. Identification of key factors influencing patient satisfaction for practical prioritization in healthcare settings: a nationwide survey analysis. Int J Qual Heal Care. 2025;37. https:\/\/doi.org\/10.1093\/intqhc\/mzaf052.","DOI":"10.1093\/intqhc\/mzaf052"},{"key":"5527_CR13","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/S00702-024-02782-2\/FIGURES\/4","volume":"131","author":"O Phokaewvarangkul","year":"2024","unstructured":"Phokaewvarangkul O, Auffret M, Groppa S, Markovic V, Petrovic I, Bhidayasiri R. What was first and what is next in selecting device-aided therapy in Parkinson\u2019s disease? Balancing evidence and experience. J Neural Transm. 2024;131:1307\u201320. https:\/\/doi.org\/10.1007\/S00702-024-02782-2\/FIGURES\/4.","journal-title":"J Neural Transm"},{"key":"5527_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11050639","author":"D Ferreira","year":"2023","unstructured":"Ferreira D, Vieira I, Pedro M, Caldas P, Varela M. Patient satisfaction with healthcare services and the techniques used for its assessment: a systematic literature review and a bibliometric analysis. Healthcare. 2023;11(5):1\u201331. https:\/\/doi.org\/10.3390\/healthcare11050639.\u00a0Healthcare (Switzerland) [revista en Internet] 2023 [acceso 8 de octubre de 2023]."},{"key":"5527_CR15","doi-asserted-by":"publisher","unstructured":"Nilsson MH, Oswald F, Palmqvist S, Slaug B. Coping styles among people with parkinson\u2019s disease: a three-year follow-up study. Behav Sci (Basel). 2020;10. https:\/\/doi.org\/10.3390\/bs10120190.","DOI":"10.3390\/bs10120190"},{"key":"5527_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/mds.21355","volume":"22","author":"P Mart\u00ednez-Mart\u00edn","year":"2007","unstructured":"Mart\u00ednez-Mart\u00edn P, Forjaz MJ, Frades-Payo B, Rusi\u00f1ol AB, Fern\u00e1ndez-Garc\u00eda JM, Benito-Le\u00f3n J, et al. Caregiver burden in Parkinson\u2019s disease. Mov Disord. 2007;22:924\u201331. https:\/\/doi.org\/10.1002\/mds.21355.","journal-title":"Mov Disord"},{"key":"5527_CR17","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s11136-024-03616-0","volume":"33","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Wu W, Wu J, Shen B, Cao Y, Xu Y. Risk factors and intervention of caregiver burden in Parkinson\u2019s disease: a systematic review and meta-analysis. Qual Life Res. 2024;33:1753\u201366. https:\/\/doi.org\/10.1007\/s11136-024-03616-0.","journal-title":"Qual Life Res"},{"key":"5527_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/ane.13260","volume":"142","author":"C Ehlers","year":"2020","unstructured":"Ehlers C, Timpka J, Odin P, Honig H. Levodopa infusion in Parkinson\u2019s disease: Individual quality of life. Acta Neurol Scand. 2020;142:248\u201354. https:\/\/doi.org\/10.1111\/ane.13260.","journal-title":"Acta Neurol Scand"},{"key":"5527_CR19","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/mds.28595","volume":"36","author":"T Tsunemi","year":"2021","unstructured":"Tsunemi T, Oyama G, Saiki S, Hatano T, Fukae J, Shimo Y, et al. Intrajejunal Infusion of Levodopa\/Carbidopa for Advanced Parkinson\u2019s Disease: A Systematic Review. Mov Disord. 2021;36:1759\u201371. https:\/\/doi.org\/10.1002\/mds.28595.","journal-title":"Mov Disord"},{"key":"5527_CR20","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3233\/JPD-223295","volume":"12","author":"KR Chaudhuri","year":"2022","unstructured":"Chaudhuri KR, Antonini A, Pahwa R, Odin P, Titova N, Thakkar S, et al. Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up. J Parkinsons Dis. 2022;12:2071\u201383. https:\/\/doi.org\/10.3233\/JPD-223295.","journal-title":"J Parkinsons Dis"},{"key":"5527_CR21","doi-asserted-by":"publisher","unstructured":"Hiseman JP, Fackrell R. Caregiver burden and the nonmotor symptoms of Parkinson\u2019s disease. Int Rev Neurobiol. 2017;479\u201397. https:\/\/doi.org\/10.1016\/bs.irn.2017.05.035.","DOI":"10.1016\/bs.irn.2017.05.035"},{"key":"5527_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/geront\/gnu177","volume":"55","author":"DL Roth","year":"2015","unstructured":"Roth DL, Fredman L, Haley WE. Informal Caregiving and Its Impact on Health: A Reappraisal From Population-Based Studies David. Gerontologist. 2015;55:309\u201319. https:\/\/doi.org\/10.1093\/geront\/gnu177.","journal-title":"Gerontologist"},{"key":"5527_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3389\/fneur.2019.00896","volume":"10","author":"FAP Nijhuis","year":"2019","unstructured":"Nijhuis FAP, van den Heuvel L, Bloem BR, Post B, Meinders MJ. The Patient\u2019s Perspective on Shared Decision-Making in Advanced Parkinson\u2019s Disease: A Cross-Sectional Survey Study. Front Neurol. 2019;10:896. https:\/\/doi.org\/10.3389\/fneur.2019.00896.","journal-title":"Front Neurol"},{"key":"5527_CR24","doi-asserted-by":"publisher","unstructured":"Leiknes I. 4. I wouldn\u2019t give up that pump: insights into the lifeworld of persons with Parkinson\u2019s disease living with pump therapy. Caring Futur. 2025;91\u2013110. https:\/\/doi.org\/10.18261\/9788215071398-25-04.","DOI":"10.18261\/9788215071398-25-04"},{"key":"5527_CR25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s00415-025-13123-y","volume":"272","author":"MJ Soileau","year":"2025","unstructured":"Soileau MJ, Kumar R, Parab A, Brion T, White K, Yan CH, et al. Patients\u2019 experience with and perspectives on long-term use of continuous subcutaneous infusion of foslevodopa\/foscarbidopa in Parkinson\u2019s disease. J Neurol. 2025;272:416. https:\/\/doi.org\/10.1007\/s00415-025-13123-y.","journal-title":"J Neurol"},{"key":"5527_CR26","doi-asserted-by":"publisher","first-page":"9516","DOI":"10.3390\/ijerph18189516","volume":"18","author":"YM Chac\u00f3n G\u00e1mez","year":"2021","unstructured":"Chac\u00f3n G\u00e1mez YM, Brugger F, Biller-Andorno N. Parkinson\u2019s Disease and Deep Brain Stimulation Have an Impact on My Life: A Multimodal Study on the Experiences of Patients and Family Caregivers. Int J Environ Res Public Health. 2021;18:9516. https:\/\/doi.org\/10.3390\/ijerph18189516.","journal-title":"Int J Environ Res Public Health"},{"key":"5527_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706QP063OA","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101. https:\/\/doi.org\/10.1191\/1478088706QP063OA.","journal-title":"Qual Res Psychol"},{"key":"5527_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/INTQHC\/MZM042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Heal Care. 2007;19:349\u201357. https:\/\/doi.org\/10.1093\/INTQHC\/MZM042.","journal-title":"Int J Qual Heal Care"},{"key":"5527_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/0147-1767(85)90062-8","volume-title":"Naturalistic inquiry","author":"Y Lincoln","year":"1985","unstructured":"Lincoln Y, Guba EG. Naturalistic inquiry. Newbury Park, California: Sage.; 1985."},{"key":"5527_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/JNN.0000000000000198","volume":"48","author":"JY Shin","year":"2016","unstructured":"Shin JY, Habermann B. Medication Adherence in People with Parkinson Disease. J Neurosci Nurs. 2016;48:185\u201394. https:\/\/doi.org\/10.1097\/JNN.0000000000000198.","journal-title":"J Neurosci Nurs"},{"key":"5527_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/13854046.2011.639312","volume":"26","author":"KJ Manning","year":"2012","unstructured":"Manning KJ, Clarke C, Lorry A, Weintraub D, Wilkinson JR, Duda JE, et al. Medication management and neuropsychological performance in Parkinson\u2019s disease. Clin Neuropsychol. 2012;26:45\u201358. https:\/\/doi.org\/10.1080\/13854046.2011.639312.","journal-title":"Clin Neuropsychol"},{"key":"5527_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/mds.27625","volume":"34","author":"C Atkinson-Clement","year":"2019","unstructured":"Atkinson-Clement C, Cavazzini \u00c9, Z\u00e9non A, Witjas T, Fluch\u00e8re F, Azulay J, et al. Effects of subthalamic nucleus stimulation and levodopa on decision\u2010making in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc. 2019;34:377\u201385. https:\/\/doi.org\/10.1002\/mds.27625.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"5527_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.parkreldis.2010.09.005","volume":"17","author":"AN Nisenzon","year":"2011","unstructured":"Nisenzon AN, Robinson ME, Bowers D, Banou E, Malaty I, Okun MS. Measurement of patient-centered outcomes in Parkinson\u2019s disease: What do patients really want from their treatment? Park Relat Disord. 2011;17:89\u201394. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.09.005.","journal-title":"Park Relat Disord"},{"key":"5527_CR34","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/MDS.21586","volume":"22","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, MacPhee G, et al. Prevalence of nonmotor symptoms in Parkinson\u2019s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007;22:1623\u20139. https:\/\/doi.org\/10.1002\/MDS.21586.","journal-title":"Mov Disord"},{"key":"5527_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/imj.13754","volume":"48","author":"N Vijiaratnam","year":"2018","unstructured":"Vijiaratnam N, Hewer S, Varley S, Paul E, Bertram KL, Lee W, et al. Levodopa-carbidopa intestinal gel: is the naso-jejunal phase a redundant convention? Intern Med J. 2018;48:469\u201371. https:\/\/doi.org\/10.1111\/imj.13754.","journal-title":"Intern Med J"},{"key":"5527_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03679.x","author":"D Nyholm","year":"2012","unstructured":"Nyholm D, Klangemo K, Johansson A. Levodopa\/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson\u2019s disease. Eur J Neurol. 2012. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03679.x.","journal-title":"Eur J Neurol"},{"key":"5527_CR37","doi-asserted-by":"publisher","unstructured":"Shin JY, Habermann B. Nursing research in caregivers of people with Parkinson\u2019s disease from 2011 to 2021: a scoping review. Appl Nurs Res. 2022;66. https:\/\/doi.org\/10.1016\/j.apnr.2022.151590. January:151590.","DOI":"10.1016\/j.apnr.2022.151590"},{"key":"5527_CR38","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.2147\/NDT.S256217","volume":"16","author":"N Modugno","year":"2020","unstructured":"Modugno N, Antonini A, Tessitore A, Marano P, Pontieri FE, Tambasco N, et al. Impact of supporting people with advanced Parkinson\u2019s disease on carer\u2019s quality of life and burden. Neuropsychiatr Dis Treat. 2020;16:2899\u2013912. https:\/\/doi.org\/10.2147\/NDT.S256217.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5527_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/S41531-021-00246-Y","volume":"7","author":"F Valldeoriola","year":"2021","unstructured":"Valldeoriola F, Catal\u00e1n MJ, Escamilla-Sevilla F, Freire E, Olivares J, Cubo E, et al. Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease. NPJ Park Dis. 2021;7:108. https:\/\/doi.org\/10.1038\/S41531-021-00246-Y.","journal-title":"NPJ Park Dis"},{"key":"5527_CR40","doi-asserted-by":"publisher","first-page":"5932865","DOI":"10.1155\/2023\/5932865","volume":"2023","author":"S Shahmoon","year":"2023","unstructured":"Shahmoon S, Limousin P, Jahanshahi M. Exploring the Caregiver Role after Deep Brain Stimulation Surgery for Parkinson\u2019s Disease: A Qualitative Analysis. Parkinsons Dis. 2023;2023:5932865. https:\/\/doi.org\/10.1155\/2023\/5932865.","journal-title":"Parkinsons Dis"},{"key":"5527_CR41","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/J.IJNURSTU.2010.03.006","volume":"47","author":"A Haahr","year":"2010","unstructured":"Haahr A, Kirkevold M, Hall EOC, \u00d8stergaard K. From miracle to reconciliation: a hermeneutic phenomenological study exploring the experience of living with Parkinson\u2019s disease following deep brain stimulation. Int J Nurs Stud. 2010;47:1228\u201336. https:\/\/doi.org\/10.1016\/J.IJNURSTU.2010.03.006.","journal-title":"Int J Nurs Stud"},{"key":"5527_CR42","doi-asserted-by":"publisher","unstructured":"Read J, Cable S, Bartl G, L\u00f6fqvist C, Iwarsson S, Schrag A. The lived experience of caregiving and perception of service provision among family-caregivers of people with late-stage Parkinson\u2019s: a qualitative study. Parkinsons Dis. 2023;4483517. https:\/\/doi.org\/10.1155\/2023\/4483517.","DOI":"10.1155\/2023\/4483517"},{"key":"5527_CR43","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1080\/09638288.2024.2387689","volume":"47","author":"CM Clarkin","year":"2025","unstructured":"Clarkin CM, Smith DG, McGough EL, Mahler LA. Centering the person in development of a model of care for people with Parkinson\u2019s disease: a qualitative study. Disabil Rehabil. 2025;47:1976\u201387. https:\/\/doi.org\/10.1080\/09638288.2024.2387689.","journal-title":"Disabil Rehabil"},{"key":"5527_CR44","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/S00702-023-02668-9","volume":"130","author":"M Auffret","year":"2023","unstructured":"Auffret M, Weiss D, Stocchi F, V\u00e9rin M, Jost WH. Access to device-aided therapies in advanced Parkinson\u2019s disease: navigating clinician biases, patient preference, and prognostic uncertainty. J Neural Transm. 2023;130:1411\u201332. https:\/\/doi.org\/10.1007\/S00702-023-02668-9.","journal-title":"J Neural Transm"},{"key":"5527_CR45","doi-asserted-by":"publisher","first-page":"e16149","DOI":"10.1111\/ene.16149","volume":"31","author":"F Cavallieri","year":"2024","unstructured":"Cavallieri F, Ghirotto L, Sireci F, Parmeggiani M, Pedroni C, Mardones FA, et al. Caregivers\u2019 burden and deep brain stimulation for Parkinson disease: A systematic review of qualitative studies. Eur J Neurol. 2024;31:e16149. https:\/\/doi.org\/10.1111\/ene.16149.","journal-title":"Eur J Neurol"},{"key":"5527_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-023-02933-4","volume":"21","author":"AD Geerlings","year":"2023","unstructured":"Geerlings AD, Kapelle WM, Sederel CJ, Tenison E, Wijngaards-Berenbroek H, Meinders MJ, et al. Caregiver burden in Parkinson\u2019s disease: a mixed-methods study. BMC Med. 2023;21:1\u201322. https:\/\/doi.org\/10.1186\/s12916-023-02933-4.","journal-title":"BMC Med"},{"key":"5527_CR47","doi-asserted-by":"publisher","first-page":"5522824","DOI":"10.1155\/2024\/5522824","volume":"2024","author":"TH Thomsen","year":"2024","unstructured":"Thomsen TH, Nielsen NS, Isenberg A, Lou, M\u00f8ller MH, Clausen JB, Schack Frederiksen IM, et al. Home-Based Titration with Duodenal Infusion of Levodopa-Carbidopa Intestinal Gel in People with Parkinson\u2019s Disease: An Observational Feasibility Study. Parkinsons Dis. 2024;2024:5522824. https:\/\/doi.org\/10.1155\/2024\/5522824.","journal-title":"Parkinsons Dis"},{"key":"5527_CR48","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1111\/jocn.16636","volume":"32","author":"MV Navarta-S\u00e1nchez","year":"2023","unstructured":"Navarta-S\u00e1nchez MV, Palmar-Santos A, Pedraz-Marcos A, Reidy C, Soilemezi D, Haahr A, et al. Perspectives of people with Parkinson\u2019s disease and family carers about disease management in community settings: A cross-country qualitative study. J Clin Nurs. 2023;32:5201\u201318. https:\/\/doi.org\/10.1111\/jocn.16636.","journal-title":"J Clin Nurs"},{"key":"5527_CR49","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1177\/1877718X251321110","volume":"15","author":"M Garon","year":"2025","unstructured":"Garon M, Weck C, Leta V, Dijkstra BW, Muente C, Gentile G, et al. Early thinking palliative care for people with Parkinson\u2019s disease: A thematic synthesis based on a systematic mixed-methods review. J Parkinsons Dis. 2025;15:710\u201358. https:\/\/doi.org\/10.1177\/1877718X251321110.","journal-title":"J Parkinsons Dis"},{"key":"5527_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cct.2019.02.005","volume":"79","author":"BM Kluger","year":"2019","unstructured":"Kluger BM, Katz M, Galifianakis N, Pantilat SZ, Kutner JS, Sillau S, et al. Does outpatient palliative care improve patient-centered outcomes in Parkinson\u2019s disease: Rationale, design, and implementation of a pragmatic comparative effectiveness trial. Contemp Clin Trials. 2019;79:28\u201336. https:\/\/doi.org\/10.1016\/j.cct.2019.02.005.","journal-title":"Contemp Clin Trials"},{"key":"5527_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2648.2012.06012.x","volume":"69","author":"A Haahr","year":"2012","unstructured":"Haahr A, Kirkevold M, Hall EOC, \u00d8stergaard K, Rn D, Hall Mscn EOC. Being in it together\u2019: living with a partner receiving deep brain stimulation for advanced Parkinson\u2019s disease-a hermeneutic phenomenological study. J Adv Nurs. 2012;69:338\u201347. https:\/\/doi.org\/10.1111\/j.1365-2648.2012.06012.x.","journal-title":"J Adv Nurs"}],"container-title":["BMC Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12912-026-05527-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12912-026-05527-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12912-026-05527-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:37:48Z","timestamp":1792604268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12912-026-05527-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5527"],"URL":"https:\/\/doi.org\/10.1186\/s12912-026-05527-6","relation":{"references":[{"id-type":"doi","id":"10.3390\/healthcare11050639","asserted-by":"subject"}]},"ISSN":["1472-6955"],"issn-type":[{"value":"1472-6955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Swedish Ethical Review Authority (2024-03848-02). All participants received written and oral information outlining the study\u2019s purpose, voluntary nature, and their right to withdraw at any time. Written informed consent was obtained. Data were pseudonymized using participant codes (e.g., P01\u2013P10), and identifying details were replaced with generic terms. Quotations were slightly edited for anonymity and gender neutrality while preserving meaning. The study followed the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1001"}}